Louisiana Oncology Associates

Lafayette, Louisiana 70508

0 studies enrolling now · 13 studies all time

What they study most

Advanced Prostate Cancer, Biliary Tract Cancer, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, Esophageal Cancer, Hormone Refractory Prostate Cancer, Lung Cancer, Non-Small-Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer, Pleural Effusion, Malignant

Studies at this site

• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed
• Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer — Completed
• Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer — Completed
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer — Status unconfirmed
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Non-small Cell Lung Cancer Registry — Completed
• XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors — Stopped early
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early
• BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment — Status unconfirmed
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus — Status unconfirmed